List view / Grid view

Janssen

FDA approval for leukaemia non-chemo combination therapy

29 January 2019 | By European Pharmaceutical Review

The FDA has approved the first ever non-chemotherapy combination treatment using ibrutinib and obinutuzumab for the most common form of adult leukaemia...

news

Ustekinumab could be approved to treat ulcerative colitis

7 January 2019 | By European Pharmaceutical Review

Ustekinumab has been submitted to be the first interleukin (IL)-12/23 inhibitor licensed for the treatment of ulcerative colitis...